Latest Industry Insights

To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff Milton, at the 2025 SLAS international meeting in San Diego.

UK Biocentre is adopting Azenta’s BioArc™ Ultra™, an automated -80°C storage system, to enhance biobanking efficiency and sustainability. With high-density storage and precise temperature control, it safeguards valuable samples.

Dr. John Lee, global head of cell and gene therapy at SK pharmteco discusses the current challenges in plasmid manufacturing and how SK pharmteco’s Precision Plasmids™ technology can help overcome plasmid production bottlenecks.

Mary Kay Bates, senior global cell culture scientist at Thermo Fisher Scientific, explores best practices for implementing GMP regulations in the lab.

Louise Digby, vice president of enzymes and bioproduction at BioProduction by SEKISUI, discusses some of the current challenges in scaling microbial fermentation for biopharmaceutical production and how a CDMO can help overcome these challenges.

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's custom antibody services team, to learn more about the developments and future directions within antibody innovation.

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.

Levi Rogers reviews organizational-level support for lab sustainability, including developing organizational sustainability commitments, employee reward programs and cross-organizational partnerships.

Cell and gene therapies are revolutionizing medicine. Looking to 2025, advancements in allogeneic therapies, streamlined autologous processes and broader applications promise increased accessibility and innovation in treating complex diseases.